Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(50.0%)
N/A
1(50.0%)
2Total
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05764343Not ApplicableCompleted

The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases

Role: collaborator

NCT04988282Phase 4Completed

Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease

Role: lead

NCT02821039Terminated

Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study

Role: lead

All 3 trials loaded